These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7906412)

  • 1. Effects of increased beta 2-agonist dose in tumor-bearing animals.
    Stallion A; Foley-Nelson T; Chance WT; Fischer JE
    Nutr Cancer; 1993; 20(3):251-60. PubMed ID: 7906412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cancer cachexia in rats by cimaterol and supplemental nutrition.
    Stallion A; Zhang FS; Chance WT; Foley-Nelson T; Fischer JE
    Surgery; 1991 Oct; 110(4):678-84. PubMed ID: 1681593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticatabolic effect of the beta 2-agonist cimaterol in vivo in tumor-bearing animals.
    Stallion A; Foley-Nelson T; Chance WT; James JH; Fischer JE
    J Surg Res; 1995 Sep; 59(3):387-92. PubMed ID: 7643598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.
    Sheppard BC; Venzon D; Fraker DL; Langstein HN; Jensen JC; Norton JA
    Cancer Res; 1990 Jul; 50(13):3928-33. PubMed ID: 2354441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
    Aversa Z; Bonetto A; Costelli P; Minero VG; Penna F; Baccino FM; Lucia S; Rossi Fanelli F; Muscaritoli M
    Int J Oncol; 2011 Mar; 38(3):713-20. PubMed ID: 21184031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin reversal of cancer cachexia in rats.
    Moley JF; Morrison SD; Norton JA
    Cancer Res; 1985 Oct; 45(10):4925-31. PubMed ID: 3896470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition changes in rats with experimental cancer cachexia: improvement with exogenous insulin.
    Moley JF; Morrison SD; Gorschboth CM; Norton JA
    Cancer Res; 1988 May; 48(10):2784-7. PubMed ID: 3282649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent effects of leucine supplementation on preservation of muscle mass in cancer cachectic mice.
    Peters SJ; van Helvoort A; Kegler D; Argilès JM; Luiking YC; Laviano A; van Bergenhenegouwen J; Deutz NE; Haagsman HP; Gorselink M; van Norren K
    Oncol Rep; 2011 Jul; 26(1):247-54. PubMed ID: 21503587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
    Langstein HN; Doherty GM; Fraker DL; Buresh CM; Norton JA
    Cancer Res; 1991 May; 51(9):2302-6. PubMed ID: 1901758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parabiotic transfer of cancer anorexia/cachexia in male rats.
    Norton JA; Moley JF; Green MV; Carson RE; Morrison SD
    Cancer Res; 1985 Nov; 45(11 Pt 1):5547-52. PubMed ID: 3863707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous intravenous infusion of ghrelin does not stimulate feeding in tumor-bearing rats.
    Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
    Nutr Cancer; 2008; 60(1):75-90. PubMed ID: 18444139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
    Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
    Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the beta-adrenergic agonist cimaterol on chicken muscle atrophy induced by stretch-release.
    Lee YB; Hitchcock L; Summers PJ
    Growth Dev Aging; 1994; 58(1):13-9. PubMed ID: 7915706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clenbuterol treatment increases muscle mass and protein content of tumor-bearing rats maintained on total parenteral nutrition.
    Chance WT; Cao LQ; Zhang FS; Foley-Nelson T; Fischer JE
    JPEN J Parenter Enteral Nutr; 1991; 15(5):530-5. PubMed ID: 1942465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
    Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral vs enteral nutrition in tumor-bearing rats.
    Stallion A; Foley-Nelson T; Chance WT; Zhang FS; Fischer JE
    JPEN J Parenter Enteral Nutr; 1994; 18(2):148-53. PubMed ID: 8201750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells.
    Fukuda T; Sumi T; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Oncol; 2009 Jan; 34(1):61-7. PubMed ID: 19082478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of insulin on doxorubicin-induced rat host toxicity and tumor regression.
    Peacock JL; Gorschboth CM; Norton JA
    Cancer Res; 1987 Aug; 47(16):4318-22. PubMed ID: 3300963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
    Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
    Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
    Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
    Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.